Background: Whether thrombolysis improves outcomes in non-arteritic central retinal artery
occlusion (naCRAO) is uncertain. We aimed to evaluate the rate of visual recovery after intra …

688 Stroke February 2020 for anerobic glycolysis. Retinal ganglion cell death sets in motion
a process of axonal degeneration with optic atrophy ensuing over a period of several weeks …

Background: An ophthalmic artery occlusion (OAO) is a partial or complete obstruction of the
ophthalmic artery and may lead to severe ischemia of the affected globe and associated …

Background: Acute nonarteritic central retinal artery occlusion (CRAO) is an eye stroke with
poor visual prognosis and no proven effective therapies. Given advances in acute stroke …

Dysfunctional endothelial cells contribute to the pathophysiology of many diseases,
including vascular disease, stroke, hypertension, atherosclerosis, organ failure, diabetes …

Background Central retinal artery occlusion (CRAO) is an ophthalmological emergency, the
retinal analog of a stroke. To date there is no consensus or national guidelines on how this …

Acute retinal arterial ischemia, which includes transient monocular vision loss (TMVL),
branch retinal artery occlusion (BRAO), central retinal artery occlusion (CRAO) and …

Background. The association between paracentral acute middle maculopathy (PAMM) and
visual acuity in patients with retinal artery occlusion (RAO) is unknown. This study explored …

Purpose To investigate the efficacy and safety of intra-arterial thrombolysis (IAT) in patients
with central retinal artery occlusion (CRAO). Methods PubMed and EMBASE were searched …

Purpose To investigate the benefit of early intra-arterial tissue plasminogen activator (IAT)
for treatment of central retinal artery occlusion (CRAO). Patients and Methods Fifteen eyes of …